Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
1.180
-0.060 (-4.84%)
At close: Nov 3, 2025, 4:00 PM EST
1.200
+0.020 (1.69%)
After-hours: Nov 3, 2025, 4:30 PM EST
Allogene Therapeutics Employees
As of December 31, 2024, Allogene Therapeutics had 229 total employees, including 226 full-time and 3 part-time employees. The number of employees decreased by 4 or -1.72% compared to the previous year.
Employees
229
Change (1Y)
-4
Growth (1Y)
-1.72%
Revenue / Employee
n/a
Profits / Employee
-$1,034,533
Market Cap
261.82M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 229 | -4 | -1.72% |
| Dec 31, 2023 | 233 | -128 | -35.46% |
| Dec 31, 2022 | 361 | 51 | 16.45% |
| Dec 31, 2021 | 310 | 45 | 16.98% |
| Dec 31, 2020 | 265 | 59 | 28.64% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ALLO News
- 8 hours ago - Allogene Therapeutics Announces ALPHA3 Trial-in-Progress Poster Presentation at ASH Annual Meeting - GlobeNewsWire
- 4 days ago - Allogene Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update - GlobeNewsWire
- 4 weeks ago - Allogene Therapeutics, Inc. (ALLO) Presents at Citi's SMID Call Series 2025 Transcript - Seeking Alpha
- 2 months ago - Allogene Therapeutics Announces Participation in Upcoming Investor Conference - GlobeNewsWire
- 2 months ago - Allogene Therapeutics: Important Catalysts Guided For Early 2026 - Seeking Alpha
- 2 months ago - Allogene Therapeutics, Inc. (ALLO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Allogene Therapeutics Reports Second Quarter 2025 Financial Results and Business Update - GlobeNewsWire
- 3 months ago - Allogene Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update - GlobeNewsWire